Publication:
The effects of iron replacement on functional capacity in patients with group 1 and group 4 pulmonary hypertension

Simple item page
dc.contributor.authorATAŞ, HALİL
dc.contributor.authorKOCAKAYA, DERYA
dc.contributor.authorYILDIZELİ, BEDRETTİN
dc.contributor.authorMUTLU, BÜLENT
dc.contributor.authorsAkaslan D., Aslanger E., ATAŞ H., Kanar B. G. , KOCAKAYA D., YILDIZELİ B., MUTLU B.
dc.date.accessioned2022-11-01T07:46:45Z
dc.date.available2022-11-01T07:46:45Z
dc.date.issued2022-10-01
dc.description.abstractObjective: Abnormal iron handling complicates pulmonary hypertension and causes functional limitation and poor outcomes. Although preliminary results in group 1 pulmonary hypertension patients support the use of iron replacement, whether this applies to other PH subgroups is not known.
dc.identifier.citationAkaslan D., Aslanger E., ATAŞ H., Kanar B. G. , KOCAKAYA D., YILDIZELİ B., MUTLU B., "The Effects of Iron Replacement on Functional Capacity in Patients with Group 1 and Group 4 Pulmonary Hypertension", TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.50, sa.7, ss.492-497, 2022
dc.identifier.doi10.5543/tkda.2022.22343
dc.identifier.endpage497
dc.identifier.issn1016-5169
dc.identifier.issue7
dc.identifier.startpage492
dc.identifier.urihttps://hdl.handle.net/11424/282757
dc.identifier.volume50
dc.language.isoeng
dc.relation.ispartofTURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectCardiovascular
dc.subjectHealth Sciences
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectCARDIAC & CARDIOVASCULAR SYSTEMS
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectKardiyoloji ve Kardiyovasküler Tıp
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectAnemia
dc.subjectchronic thromboembolic pulmonary hypertension
dc.subjectferric carboxymaltose
dc.subjectpulmonary arterial hypertension
dc.subjectpulmonary hypertension
dc.subjectIMPROVES EXERCISE CAPACITY
dc.subjectQUALITY-OF-LIFE
dc.subjectARTERIAL-HYPERTENSION
dc.subjectDEFICIENCY
dc.subjectTHERAPY
dc.titleThe effects of iron replacement on functional capacity in patients with group 1 and group 4 pulmonary hypertension
dc.typearticle
dspace.entity.typePublication
local.avesis.idfcda84f5-ecd3-4ab6-97c6-1294a27c668e
local.indexed.atWOS
local.indexed.atPUBMED
local.indexed.atSCOPUS
relation.isAuthorOfPublicationbce15984-74f0-4f95-ab80-0cec144603fe
relation.isAuthorOfPublication2771cdd6-7c3b-45a8-89fe-a429a2950516
relation.isAuthorOfPublicationd6b68c67-eea7-4dc3-8688-e8cfbe3bbcd2
relation.isAuthorOfPublicationeed1d57d-2fc5-4da3-ab50-89ce22ccf43a
relation.isAuthorOfPublication.latestForDiscoverybce15984-74f0-4f95-ab80-0cec144603fe

Files

Collections

Research Outputs